Hybrid Electric-Acoustic Stimulation (EAS) Cochlear Implant for High-Frequency Hearing Loss
Yes, a Hybrid EAS cochlear implant is indicated for patients with preserved low-frequency hearing (≤30 dB HL at 250-500 Hz) and severe-to-profound high-frequency hearing loss (≥70 dB HL at 2 kHz and above), provided they have appropriately fit amplification with persistent poor speech understanding.
Candidacy Criteria
The patient profile described matches the established criteria for Hybrid EAS cochlear implantation. The key audiometric requirements are:
- Low-frequency preservation: Thresholds ≤30 dB HL at 250 Hz and 500 Hz (patient meets this)
- High-frequency loss: Pure-tone average ≥70 dB HL at 2 kHz and above (patient meets this)
- Functional speech limitation: Poor speech understanding despite appropriately fit hearing aids 1
Evidence for Benefit
The most recent multicenter trial data demonstrates compelling outcomes for this exact patient population 2. In 52 adults followed for up to 5 years:
- 77% maintained functionally aidable hearing (low-frequency PTA <80 dB HL) through 1 year, with 66.7% maintaining through 5 years
- Significant speech perception improvements at all postoperative timepoints compared to preoperative hearing aid performance
- Enhanced spatial hearing and sound quality in patients who preserved acoustic hearing using EAS versus electric-only stimulation
The pivotal US multicenter trial showed even more dramatic improvements 3:
- Mean improvement of 35.8 percentage points on CNC words (P<0.001)
- Mean improvement of 32.0 percentage points on AzBio sentences in noise (P<0.001)
- 96% performed equal or better in quiet; 90% in noise
- 82% showed improved performance in quiet; 74% in noise
Clinical Decision Algorithm
Step 1: Verify hearing aid optimization
- Confirm real-ear measures show hearing aids meet prescriptive targets 1
- Some patients may simply have under-amplification rather than true CI candidacy
Step 2: Document speech understanding limitations
- Perform CNC word testing and sentence-in-noise testing
- The "60/60" guideline (PTA ≥60 dB, word scores ≤60%) has 96% sensitivity for identifying CI candidates 1
- Your patient exceeds these thresholds at high frequencies
Step 3: Refer for formal CI evaluation
- Given preserved low-frequency hearing and severe high-frequency loss, specifically request evaluation for Hybrid/EAS candidacy rather than standard CI
- The short electrode array (typically 16-24mm) preserves the apical cochlea where low-frequency hearing resides 3, 4
Critical Advantages of EAS Over Standard CI
Patients with your described profile gain specific benefits from EAS that standard cochlear implants cannot provide 2:
- Preservation of acoustic cues: Fundamental frequency, temporal fine structure, and interaural time differences
- Superior music perception: Better melody and instrument recognition 4
- Enhanced noise performance: The combination of electric high-frequency and acoustic low-frequency stimulation provides synergistic benefit
- Bilateral acoustic hearing: When combined with contralateral hearing aid, provides superior spatial hearing 2
Prognostic Factors
Younger age at implantation predicts better outcomes 5:
- Greater likelihood of maintaining functionally aidable hearing
- Superior speech-in-noise improvements
- Better long-term audiometric stability (typically stabilizes around 1 year post-activation)
Common Pitfalls to Avoid
Do not delay referral based on the misconception that residual hearing will be lost. The 2024 AAO-HNS guidelines emphasize significant under-utilization, with only 5-12.7% of potential candidates receiving devices 1. Clinicians often fail to recognize that expanding candidacy criteria now include patients with substantial residual hearing.
Do not assume standard CI is the only option. Patients with this specific audiometric pattern (preserved low frequencies, severe high-frequency loss) are ideal Hybrid candidates, not standard CI candidates. Using a full-length electrode in these patients may unnecessarily sacrifice residual hearing 6.
Do not wait for complete hearing loss. In progressive losses, early intervention with Hybrid CI captures the benefit window while acoustic hearing remains functional 5.
Underutilization Context
The guidelines explicitly state that clinician knowledge gaps contribute to massive underutilization of CI technology 1. Your patient represents a textbook Hybrid EAS candidate who would likely experience significant quality of life improvement through timely referral.